Minneapolis Heart Institute Foundation
Clinical trials sponsored by Minneapolis Heart Institute Foundation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New balloon tackles tough heart blockages in major registry Results expected Jan 2027 (estimated)
- Could your voice reveal hidden burnout? a new study investigates Results expected Jun 2027 (estimated)
- MRI scans may predict who benefits from MitraClip heart valve repair Results expected Jul 2027 (estimated)
- Which access route for heart catheterization causes fewer bleeding complications? Results expected Aug 2027 (estimated)
-
Can a vein in the heart offer a safer route for pacemaker leads?
Disease control Not yet recruitingThis trial tests whether a specific pacemaker lead, the Medtronic 3830, can be safely implanted through the middle cardiac vein in people who have had or plan to have tricuspid valve intervention. The goal is to see if this route provides stable pacing and sensing without causing…
Sponsor: Minneapolis Heart Institute Foundation • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a defibrillator lead thread through the Heart's middle cardiac vein?
Symptom relief Not yet recruitingResearchers are testing a new defibrillator lead called the Medtronic OmniaSecure Model 3930M in people who need a defibrillator and also have moderate or worse tricuspid valve regurgitation. The lead is placed through the middle cardiac vein, a different route than usual, with t…
Sponsor: Minneapolis Heart Institute Foundation • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC